Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,212,300 papers from all fields of science
Search
Sign In
Create Free Account
Tiludronate
Known as:
(chloro-4-phenyl)thiomethylene biphosphonate
, (chloro-4-phenyl)thiomethylene bisphosphonate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Diphosphonates
Drug Allergy
Paget Disease Extramammary
Narrower (1)
Tiludronate disodium
Broader (1)
tiludronic acid
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy.
C. Leu
,
E. Luegmayr
,
L. Freedman
,
G. Rodan
,
A. Reszka
Bone
2006
Corpus ID: 22527570
Review
2004
Review
2004
From Molds and Macrophages to Mevalonate: A Decade of Progress in Understanding the Molecular Mode of Action of Bisphosphonates
M. Rogers
Calcified Tissue International
2004
Corpus ID: 24438016
Although bisphosphonates were first used as therapeutic agents to inhibit bone resorption in the early 1970s, their mode of…
Expand
Review
2003
Review
2003
New insights into the molecular mechanisms of action of bisphosphonates.
M. Rogers
Current pharmaceutical design
2003
Corpus ID: 22525479
Bisphosphonates are currently the most important and effective class of anti-resorptive drugs available, but the exact molecular…
Expand
Highly Cited
2000
Highly Cited
2000
Protein Geranylgeranylation Is Required for Osteoclast Formation, Function, and Survival: Inhibition by Bisphosphonates and GGTI‐298
F. Coxon
,
M. Helfrich
,
+4 authors
M. Rogers
Journal of Bone and Mineral Research
2000
Corpus ID: 23634796
Bisphosphonates are the important class of antiresorptive drugs used in the treatment of metabolic bone diseases. Although their…
Expand
Review
2000
Review
2000
Oral bisphosphonates
P. Major
,
A. Lipton
,
James Berenson
,
G. Hortobagyi
Cancer
2000
Corpus ID: 29427931
This study was conducted to review the efficacy and safety of oral bisphosphonates for the treatment of bone metastases in cancer…
Expand
Highly Cited
2000
Highly Cited
2000
Characterization of the trabecular rat bone mineral: effect of ovariectomy and bisphosphonate treatment.
S. Bohic
,
C. Rey
,
+5 authors
G. Daculsi
Bone
2000
Corpus ID: 45155675
Review
1999
Review
1999
Bisphosphonates: from the laboratory to the clinic and back again.
R. Russell
,
M. Rogers
Bone
1999
Corpus ID: 34863390
Highly Cited
1996
Highly Cited
1996
The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H+‐ATPase
P. David
,
Hieu Nguyen
,
A. Barbier
,
R. Baron
Journal of Bone and Mineral Research
1996
Corpus ID: 43107487
Although bisphosphonates have been shown to be potent inhibitors of osteoclast‐mediated bone resorption in vivo and in vitro and…
Expand
Highly Cited
1995
Highly Cited
1995
Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
C. Roux
,
C. Gennari
,
+7 authors
M. Dougados
Arthritis & Rheumatism
1995
Corpus ID: 43907931
OBJECTIVE To compare the efficacy and safety of tiludronate and etidronate at the same dosage (400 mg/day) for the treatment of…
Expand
Highly Cited
1995
Highly Cited
1995
Therapeutic strategy in Paget's disease of bone.
P. Meunier
,
E. Vignot
Bone
1995
Corpus ID: 25786395
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE